blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1420018

EP1420018 - Pyrido¬1,2-a benzimidazole derivatives useful in treating central nervous system disorders [Right-click to bookmark this link]
Former [2004/21]Pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders
[2007/46]
StatusThe application is deemed to be withdrawn
Status updated on  18.05.2007
Database last updated on 31.08.2024
Most recent event   Tooltip12.10.2007Change - German titlepublished on 14.11.2007  [2007/46]
Applicant(s)For all designated states
Ortho-McNeil Pharmaceutical, Inc.
U.S. Route No. 202, P.O. Box 300
Raritan, NJ 08869-0602 / US
[N/P]
Former [2004/21]For all designated states
Ortho-McNeil Pharmaceutical, Inc.
U.S. Route No.202, P.O. Box 300
Raritan, NJ 08869-0602 / US
Inventor(s)01 / Reitz, Allen B.
109 Greenbriar Road
Lansdale, PA 19446 / US
02 / Jordan, Alfonzo D.
106 Victoria Lane
Horsham, PA 19044 / US
03 / Sanfilippo, Pauline J.
7 Quimby Lane
Flemington, NJ 08822 / US
04 / Scott, Malcolm K.
1036 Barley Way
Lansdale, PA 19446 / US
05 / Smith, Anna V.
3138 Burks Lane
Austin, TX 78732 / US
 [2004/21]
Representative(s)Mercer, Christopher Paul, et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2004/21]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date03078326.003.10.1997
[2004/21]
Priority number, dateUS19960027511P07.10.1996         Original published format: US 27511 P
[2004/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1420018
Date:19.05.2004
Language:EN
[2004/21]
Search report(s)(Supplementary) European search report - dispatched on:EP31.03.2004
ClassificationIPC:C07D471/04, A61K31/435
[2004/21]
CPC:
C07D471/04 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2004/21]
Extension statesSI01.11.2004
TitleGerman:Pyrido¬1,2-a benzimidazol-Derivate zur Behandlung von Erkrankungen des zentralen Nervensystems[2007/46]
English:Pyrido¬1,2-a benzimidazole derivatives useful in treating central nervous system disorders[2007/46]
French:Derives de pyrido¬1,2-a benzimidazole utiles dans le traitement des troubles du systeme nerveux central[2007/46]
Former [2004/21]Pyrido[1,2-a]benzimidazol-Derivate zur Behandlung von Erkrankungen des zentralen Nervensystems
Former [2004/21]Pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders
Former [2004/21]Derives de pyrido[1,2-a]benzimidazole utiles dans le traitement des troubles du systeme nerveux central
Examination procedure29.10.2004Examination requested  [2004/53]
26.04.2005Despatch of a communication from the examining division (Time limit: M06)
31.10.2005Reply to a communication from the examining division
14.11.2005Despatch of a communication from the examining division (Time limit: M04)
21.03.2006Reply to a communication from the examining division
01.08.2006Communication of intention to grant the patent
12.12.2006Application deemed to be withdrawn, date of legal effect  [2007/25]
18.01.2007Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2007/25]
Parent application(s)   TooltipEP97909992.6  / EP0935598
Fees paidRenewal fee
21.10.2003Renewal fee patent year 03
21.10.2003Renewal fee patent year 04
21.10.2003Renewal fee patent year 05
21.10.2003Renewal fee patent year 06
21.10.2003Renewal fee patent year 07
14.10.2004Renewal fee patent year 08
12.10.2005Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.10.200610   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9404532  (MCNEILAB INC [US], et al) [A] 1-21 * claim 1; tables 1-4,6,7 *;
 [A]US5521200  (HO WINSTON [US], et al) [A] 1-21* the whole document *;
 [A]  - MARYANOFF B E ET AL, "POTENTIAL ANXIOLYTIC AGENTS. PYRIDOLU1,2-ABENZIMIDAZOLES: A NEW STRUCTURAL CLASS OF LIGANDS FOR THE BENZODIAZEPINE BINDING SITE ON GABA-A RECEPTORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1995), vol. 38, ISSN 0022-2623, pages 16 - 20, XP002053732 [A] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00001a005
 [A]  - MARYANOFF B E ET AL, "POTENTIAL ANIOLYTIC AGENTS. 2. IMPROVEMENT OF ORAL EFFICACY FOR THEPYRIDOU1,2-ABENZIMIDAZOLE (PBI) CLASS OF GABA-A RECEPTOR MODULATORS", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (1996), vol. 6, no. 3, ISSN 0960-894X, pages 333 - 338, XP002054104 [A] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1016/0960-894X(96)00025-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.